3-(1',1'-Dimethylbutyl)-1-deoxy-Δ8-THC and related compounds: Synthesis of selective ligands for the CB2 receptor

Bioorganic and Medicinal Chemistry

Volumn 7, Issue 12, 1999, Pages 2905-2914

  Huffman, John W ^a   Liddle, John ^a   Yu, Shu ^a   Aung, Mie Mie ^b   Abood, Mary E ^b   Wiley, Jenny L ^b   Martin, Billy R ^b  

^a CLEMSON UNIVERSITY   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cannabinoid; CB2 receptor; Deoxy cannabinoid; Structure activity relationships

Indexed keywords

1 DEOXY 11 HYDROXY DELTA8 TETRAHYDROCANNABINOL; 1 DEOXY 3 (1,1 DIMETHYLBUTYL) DELTA8 TETRAHYDROCANNABINOL; 1 DEOXY 3 BUTYL DELTA8 TETRAHYDROCANNABINOL; 1 DEOXY DELTA8 TETRAHYDROCANNABINOL; CANNABINOID 1 RECEPTOR; CANNABINOID 2 RECEPTOR; CANNABINOID RECEPTOR; DELTA8 TETRAHYDROCANNABINOL; DELTA8 TETRAHYDROCANNABINOL DERIVATIVE; DEOXYNABILONE; DEOXYNABILONE DERIVATIVE; DRONABINOL; RECEPTOR SUBTYPE; TETRAHYDROCANNABINOL DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; CARBON NUCLEAR MAGNETIC RESONANCE; CONTROLLED STUDY; DRUG RECEPTOR BINDING; DRUG SELECTIVITY; DRUG SYNTHESIS; HUMAN; HUMAN CELL; PROTON NUCLEAR MAGNETIC RESONANCE; RECEPTOR AFFINITY; STRUCTURE ACTIVITY RELATION;

ANIMALS; CANNABINOIDS; CELL LINE; HUMANS; KINETICS; LIGANDS; MAGNETIC RESONANCE SPECTROSCOPY; RECEPTORS, CANNABINOID; RECEPTORS, DRUG; STRUCTURE-ACTIVITY RELATIONSHIP; TETRAHYDROCANNABINOL;

EID: 0033381793     PISSN: 09680896     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0968-0896(99)00219-9     Document Type: Article

References (22)

1. Razdan R.K. Pharmacol. Rev. 38:1986;75.
2. Rapaka, R. S.; Makriyannis, A. Structure-Activity Relationships of the Cannabinoids. NIDA Research Monograph 79, National Institute on Drug Abuse, Rockville, MD, 1987.
3. Melvin L.S., Milne G.M., Johnson M.R., Subramian B., Wilken G.H., Howlett A.C. Mol. Pharmacol. 44:1993;1008.
4. Huffman J.W., Yu S., Showalter V., Abood M.E., Wiley J.L., Compton D.R., Martin B.R., Bramblett R.D., Reggio P.H. J. Med. Chem. 39:1996;3875.
5. Gareau Y., Dufresne C., Gallant M., Rochette C., Sawyer N., Slipetz D.M., Tremblay N., Weech P.K., Metters K.M., Labelle M. Bioorg. Med. Chem. Lett. 6:1996;189.
6. Showalter V.M., Compton D.R., Martin B.R., Abood M.E. J. Pharmacol. Exp. Ther. 278:1996;989.
7. Song Z.H., Bonner T.I. Mol. Pharmacol. 49:1996;891.
8. Chin C., Lucas-Lenard J., Abadji V., Kendall D.A. J. Neurochem. 70:1998;366.
9. Huffman J.W., Zhang X., Wu M.-J., Joyner H.H., Pennington W.T. J. Org. Chem. 56:1991;1481.
10. Huffman J.W., Joyner H.H., Lee M.D., Jordan R.D., Pennington W.T. J. Org. Chem. 56:1991;2081.
11. Dominianni S.J., Ryan C.W., De Armitt C.W. J. Org. Chem. 42:1977;344.
12. Petrzilka T., Sikemeier C. Helv. Chim. Acta. 50:1967;1416.
13. Compton D.R., Rice K.C., De Costa B.R., Razdan R.K., Melvin L.S., Johnson M.R., Martin B.R. J. Pharmacol. Exp. Ther. 265:1993;218.
14. Reggio P.H., Panu A.M., Miles S. J. Med. Chem. 36:1993;1761.
15. Reggio P.H., Greer K.V., Cox S.M. J. Med. Chem. 32:1989;1630.
16. Tius, M. A.; Kawakami, J. K.; Hill, W. G. A.; Makriyannis, A. Chem. Commun. 1996, 2085.
17. Alles G.A., Icke R.N., Feigen G.A. J. Am. Chem. Soc. 64:1942;2031.
18. Smith R.M. J. Forensic Sci. 42:1997;610.
19. Edery H., Grunfeld Y., Porath G., Ben-Zvi Z., Shani A., Mechoulam R. Arzneim.-Forsch. 22:1972;1995.
20. Petrzilka T., Haefliger W., Sikemeier C. Helv. Chim. Acta. 52:1969;1102.
21. Martin B.R., Compton D.R., Thomas B.F., Prescott W.R., Little P.J., Razdan R.K., Johnson M.R., Melvin L.S., Mechoulam R., Ward S. J. Pharmacol. Biochem. Behav. 40:1991;471.
22. Cheng Y.C., Prusoff W.H. Biochem. Pharmacol. 22:1973;3099.